Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-identifies-outcome-indicators-for-benign-prostatic-hyperplasia-patients-receiving-prostatic-artery-embolisation
https://www.med.cuhk.edu.hk/press-releases/cuhk-identifies-outcome-indicators-for-benign-prostatic-hyperplasia-patients-receiving-prostatic-artery-embolisation

CUHK Identifies Outcome Indicators for Benign Prostatic Hyperplasia Patients Receiving Prostatic Artery Embolisation

Benign prostatic hypertrophy (BPH) is a common global health problem among middle-aged and older men which may gradually give rise to very disturbing urinary symptoms. The Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) has conducted a clinical study on 82 BPH patients receiving Prostatic Artery Embolisation (PAE), a new treatment for BPH. Study results showed that over 80% of the patients had favourable treatment outcomes. For those with post-procedure adverse events related to bladder outlet obstruction, most of them were having intravesical prostatic protrusion with thickness-to-height (T/H) ratio less than or equal to 1.3. 

 

Researchers concluded that the presence of intravesical prostatic protrusion with a T/H ratio less than or equal to 1.3 is an indicator for treatment outcome and occurrence of post-procedure adverse events in BPH patients receiving PAE. The study results have been published in the Journal of Vascular and Interventional Radiology.

 

PAE treatment outcome indicators

A study conducted by CU Medicine confirmed that the thickness-to-height (T/H) ratio of intravesical prostatic protrusion can effectively predict the treatment outcome and occurrence of post-procedure adverse events in benign prostatic hypertrophy (BPH) patients receiving Prostatic Artery Embolisation (PAE). 

 

 

(From left) Professor Simon YU, Chairman of the Department of Imaging and Interventional Radiology; BPH patient Mr. Tam; and Professor Anthony NG, Director of the S.H. HO Urology Centre of the Department of Surgery, CU Medicine. 

 

Over 80% of the patients receiving Prostatic Artery Embolisation show favourable clinical outcomes 

 

The prostate is a male sex gland which produces a thick fluid that forms part of the semen. BPH is non-malignant enlargement of the prostate gland which may gradually progress to a compression of the urethral canal. This causes an obstruction of the urethra and interferes with the normal flow of urine. Clinical consequences include acute urinary retention, chronic urinary retention and renal failure. According to the Department of Health of the Hong Kong Government, BPH affects more than half of men aged over 60 years, and up to 90% of men aged over 80 years. 

 

BPH patients may be prescribed with medical treatment depending on the size of the prostate gland and the symptoms. If the disease progresses and leads to voiding dysfunction, patients may need to consider surgical treatment. Since 2014, the Department of Imaging and Interventional Radiology at CU Medicine has conducted a clinical study for patients to be treated with PAE, a minimally invasive interventional procedure. It involves embolisation of the prostate using microspheres of 100 to 300 micron in diameter through superselective catheterisation of the prostate arteries under X-ray control. Embolisation leads to ischemic necrosis and volume reduction of the prostate.

 

The principle investigator of the study, Professor Simon Chun Ho YU, who is the Chairman of the Department of Imaging and Interventional Radiology at CU Medicine, remarked, “82 patients with BPH were treated with PAE from 2015 to 2018 and followed for 3 years. The presence of intravesical prostatic protrusion and its T/H ratio were assessed at baseline using magnetic resonance imaging. Post-procedure adverse events of urinary obstruction within 30 days after PAE were assessed, including acute retention of urine, deterioration in lower urinary tract symptoms, and transient obstruction due to urethral passage of tissue. The long-term clinical outcome of patients after PAE was also observed.”

 

Study results showed that 69 of the 82 patients (84.1%) had favourable clinical outcomes after PAE. The International Prostate Symptom Score of these patients dropped from 21 at baseline to below 9 after the treatment, indicating that symptoms such as urinary urgency, urinary hesitancy, frequent urination, and weak urine flow were much relieved. These outcomes can last up to 3 years.

 

Prof. Simon You

Professor Simon Yu states that results of the current study help to predict the treatment outcome of PAE before it is done and allow doctors to select the most appropriate treatment option for the greatest benefit of patients with BPH.

 

Prof. Anthony Ng

Compared to transurethral resection of the prostate, which is the usual treatment for BPH, Professor Anthony Ng says that PAE has the obvious advantages of being minimally invasive, with no need for general anesthesia and almost no blood loss. 

 

Study results facilitate the selection of optimal patients to receive Prostatic Artery Embolisation

 

For those who had poor clinical outcomes and adverse events after PAE, 12 of the 13 patients had the problem of intravesical prostatic protrusion with a T/H ratio less than or equal to 1.3. These patients needed subsequent medical treatment or even hospital readmission and/or surgery. Therefore, the T/H ratio of intravesical prostatic protrusion can be used before PAE as an outcome indicator for the treatment.

 

Professor Anthony Chi Fai NG, Director, S.H. HO Urology Centre, Department of Surgery at CU Medicine, remarked, “Compared to transurethral resection of the prostate, which is the usual treatment for BPH, PAE has the obvious advantages of being minimally invasive, with no need for general anesthesia, almost no blood loss, and a minimal risk of sexual dysfunction after the treatment. We knew PAE is a safe and effective treatment. Now we know more about the possible treatment outcomes and the factors affecting it, the identification of a useful outcome indicator for PAE is greatly helpful to doctors in the pre-treatment assessment of patients for PAE.” 

 

BPH patient Mr Tam

Mr Tam suffered from BPH for many years. He had to stay in the toilet for almost an hour because of retention of urine, and eventually needed to call an ambulance. After receiving PAE, all symptoms are relieved and now he can enjoy normal social life, such as going hiking with his friends. 

 

Professor YU concluded, “From the results of our study on PAE in the last 6 years, we know that PAE is a treatment with long-term effectiveness, which means patients with BPH have an effective and minimally invasive treatment option. Although PAE could be a risky procedure, our previous study has provided technological improvement in the procedure of PAE. In the current study, we have provided an outcome indicator for PAE which is brand new. We believe it helps to predict the treatment outcome of PAE before it is done and allows doctors to select the most appropriate treatment option for the greatest benefit of patients with BPH. The identification of this outcome indicator is important for the clinical application of PAE, which is well accepted by international experts in PAE, because it is currently the only predictor that precisely indicates which kind of prostate in BPH patients is not suitable for PAE.”

More Press Releases

CUHK’s New Prostatic Artery Embolization Shows 90% Success Rate in Relieving Symptoms of Benign Prostatic Hyperplasia

CUHK’s New Prostatic Artery Embolization Shows 90% Success Rate in Relieving Symptoms of Benign Prostatic Hyperplasia

Clinical service
CUHK and HKBU Launch Spermine Risk Score for Prostate Cancer Diagnosis

CUHK and HKBU Launch Spermine Risk Score for Prostate Cancer Diagnosis

Research
CU Medicine Studies Highlight Smoking as a Contributing Factor for Bladder Cancer and  Develop an International Collaborative Consensus on En Bloc Resection to Treat the Disease

CU Medicine Studies Highlight Smoking as a Contributing Factor for Bladder Cancer and Develop an International Collaborative Consensus on En Bloc Resection to Treat the Disease

Research
CUHK Successfully Conducted the World’s First Multi-Specialty Clinical Trial Using the Next Generation Single Port Robotic Surgical System

CUHK Successfully Conducted the World’s First Multi-Specialty Clinical Trial Using the Next Generation Single Port Robotic Surgical System

Surgical advancement
CUHK Proves Prostate Artery Embolization Effective for Benign Prostatic Hyperplasia

CUHK Proves Prostate Artery Embolization Effective for Benign Prostatic Hyperplasia

Research
CUHK Proves Modified HIFU Treatment Effective for Treating Uterine Fibroids

CUHK Proves Modified HIFU Treatment Effective for Treating Uterine Fibroids

Research
CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

Research
CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

Research
CUHK Opens S.H. Ho Urology Centre to Promote Earlier Diagnosis and Management of Prostate Cancer to the Territory

CUHK Opens S.H. Ho Urology Centre to Promote Earlier Diagnosis and Management of Prostate Cancer to the Territory

Clinical service
CUHK Assessed and Treated Over 300 Young Ketamine Abusers with Urinary Tract Dysfunction Latest Research Reveals Effectiveness of Integrated Anti-inflammatory Therapy

CUHK Assessed and Treated Over 300 Young Ketamine Abusers with Urinary Tract Dysfunction Latest Research Reveals Effectiveness of Integrated Anti-inflammatory Therapy

Research
CU Medicine Study Proves Pocket-size Mobile Echocardiographic Screening Device Effective in Detecting Thoracic Aortic Aneurysm

CU Medicine Study Proves Pocket-size Mobile Echocardiographic Screening Device Effective in Detecting Thoracic Aortic Aneurysm

Research
Results of the First 3,500 Participants of the CUHK Jockey Club Multi-Cancer Prevention Programme Demonstrate that “One-stop Multi-Cancer Screening” is Effective

Results of the First 3,500 Participants of the CUHK Jockey Club Multi-Cancer Prevention Programme Demonstrate that “One-stop Multi-Cancer Screening” is Effective

Health Campaign
CUHK Successfully Performed World’s First Colorectal Endoscopic Submucosal Dissection  Using Flexible Endoscopic Robotic System

CUHK Successfully Performed World’s First Colorectal Endoscopic Submucosal Dissection Using Flexible Endoscopic Robotic System

Surgical advancement
CU Medicine Survey Shows Global Urological Services have been Significantly Deferred due to COVID-19 Pandemic

CU Medicine Survey Shows Global Urological Services have been Significantly Deferred due to COVID-19 Pandemic

Research
CUHK Successfully Conducts Asia-Pacific’s First Hybrid Operating Room Non-invasive Bronchoscopic Microwave Ablation to Treat Lung Cancer

CUHK Successfully Conducts Asia-Pacific’s First Hybrid Operating Room Non-invasive Bronchoscopic Microwave Ablation to Treat Lung Cancer

Surgical advancement
CUHK Deepening Ties with World Leading Institutes for Transdisciplinary Medical Robotics Research to Reshape the Future of Diagnosis and Treatment

CUHK Deepening Ties with World Leading Institutes for Transdisciplinary Medical Robotics Research to Reshape the Future of Diagnosis and Treatment

International collaboration
CUHK Pioneers Early Lung Cancer Treatment with Hybrid Operating Room Image Guided Electromagnetic Navigation Bronchoscopy

CUHK Pioneers Early Lung Cancer Treatment with Hybrid Operating Room Image Guided Electromagnetic Navigation Bronchoscopy

Surgical advancement
CUHK-DGIST-ETH Zurich Establish Joint Laboratory on Nano-technology for Gastrointestinal and Cardiovascular Diseases

CUHK-DGIST-ETH Zurich Establish Joint Laboratory on Nano-technology for Gastrointestinal and Cardiovascular Diseases

International collaboration
World’s First Large-scale Epidemiological Survey on Adolescents by CUHK Reveals Abuse of Methamphetamine Associated with Increased Risk of Developing Lower Urinary Tract Symptoms

World’s First Large-scale Epidemiological Survey on Adolescents by CUHK Reveals Abuse of Methamphetamine Associated with Increased Risk of Developing Lower Urinary Tract Symptoms

Clinical service
CUHK Sets up the Global First Research Registry on Early Onset Dementia in Chinese Population

CUHK Sets up the Global First Research Registry on Early Onset Dementia in Chinese Population

Research
CUHK Screening Reveals 1 in 3 Older Adults in Community Suffer Brain Small Vessel Disease, Early Prevention Recommended

CUHK Screening Reveals 1 in 3 Older Adults in Community Suffer Brain Small Vessel Disease, Early Prevention Recommended

Clinical service
CUHK Introduces High Frequency Oscillations to Determine Resection Margin Increases the Effectiveness of Complex Epilepsy Surgery by around 30%

CUHK Introduces High Frequency Oscillations to Determine Resection Margin Increases the Effectiveness of Complex Epilepsy Surgery by around 30%

Surgical advancement
CUHK and PWH Introduce Leading 3D Imaging System which Reduces Radiation Dosage by 90%

CUHK and PWH Introduce Leading 3D Imaging System which Reduces Radiation Dosage by 90%

Clinical service
CUHK Succeeds in Treating Gastroesophageal Reflux Disease by Implantable Pulse Generator

CUHK Succeeds in Treating Gastroesophageal Reflux Disease by Implantable Pulse Generator

Surgical advancement
CUHK-PWH Hybrid Cardiovascular Operating Theatre Officially Opens Multi-functional Setting Enhances Surgical Outcomes

CUHK-PWH Hybrid Cardiovascular Operating Theatre Officially Opens Multi-functional Setting Enhances Surgical Outcomes

Clinical service
CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.